Wen Chen Yeh

Chief Tech/Sci/R&D Officer en Surrozen Operating, Inc. .

61 años

Health Technology

Consumer Services

Perfil

Wen Chen Yeh is currently the Chief Scientific Officer at Surrozen Operating, Inc. He previously worked at Amgen, Inc. as a Scientific Executive Director from 2006 to 2016.
He also worked as a Professor at the University of Toronto.
In addition, he was the former Chief Scientific Officer at Surrozen, Inc. from 2016 to 2023.
Mr. Yeh holds a doctorate degree from The Johns Hopkins University and National Taiwan University.

Cargos activos de Wen Chen Yeh

Empresas	Cargo	Inicio
Surrozen Operating, Inc. Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA.	Chief Tech/Sci/R&D Officer	01/05/2016

Todos los cargos activos de Wen Chen Yeh

Antiguos cargos conocidos de Wen Chen Yeh.

Empresas	Cargo	Fin
SURROZEN, INC.	Chief Tech/Sci/R&D Officer	31/07/2023
AMGEN INC.	Chief Tech/Sci/R&D Officer	01/04/2016
University of Toronto	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Wen Chen Yeh.

Formación de Wen Chen Yeh.

The Johns Hopkins University	Doctorate Degree
National Taiwan University	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Wen Chen Yeh.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
AMGEN INC.	Health Technology
SURROZEN, INC.	Health Technology

Empresas privadas	1
Surrozen Operating, Inc. Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA.	Health Technology